• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2'-碳脱氧鸟苷对慢性感染鸭乙型肝炎病毒的鸭子的抗病毒作用的表征

Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus.

作者信息

Mason W S, Cullen J, Saputelli J, Wu T T, Liu C, London W T, Lustbader E, Schaffer P, O'Connell A P, Fourel I

机构信息

Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.

出版信息

Hepatology. 1994 Feb;19(2):398-411.

PMID:8294097
Abstract

This study was carried out to evaluate benefits and limitations of long-term therapy of hepatitis B virus infections with a nucleoside analog inhibitor of virus replication. The model we used was the domestic duck chronically infected with duck hepatitis B virus by in ovo infection. 2' Carbodeoxyguanosine was used as an inhibitor of viral DNA synthesis. In all animals examined there was a reduction in virus production during therapy. A dose of 2' carbodeoxyguanosine of 10 micrograms/kg every other day reduced the number of infected hepatocytes from greater than 95% to 25% to 50% in less than 3 mo, whereas a 10-fold higher dose produced a decline to less than 10%. Histological evaluation revealed mild to moderate liver injury in ducks receiving the higher dose of 2' carbodeoxyguanosine, suggesting that disappearance of infected hepatocytes may have been accelerated by a toxic effect of the drug. Drug treatment did not completely eliminate duck hepatitis B virus from any duck, and replication was restored in all hepatocytes within a few weeks to several months after antiviral therapy was terminated. Our results suggest that elimination of a chronic infection with a single inhibitor of replication may be difficult in a host that lacks an antiviral immune response capable of eliminating at least a portion of the infected hepatocytes and of ultimately producing antibodies capable of neutralizing residual virus.

摘要

本研究旨在评估使用核苷类似物病毒复制抑制剂对乙型肝炎病毒感染进行长期治疗的益处和局限性。我们使用的模型是通过卵内感染慢性感染鸭乙型肝炎病毒的家鸭。2'-碳脱氧鸟苷用作病毒DNA合成的抑制剂。在所有接受检查的动物中,治疗期间病毒产生量均有所减少。每隔一天给予10微克/千克的2'-碳脱氧鸟苷剂量,在不到3个月的时间内,感染肝细胞的数量从超过95%降至25%至50%,而剂量高出10倍则使感染肝细胞数量降至不到10%。组织学评估显示,接受较高剂量2'-碳脱氧鸟苷的鸭子出现轻度至中度肝损伤,这表明药物的毒性作用可能加速了感染肝细胞的消失。药物治疗未能使任何一只鸭子的鸭乙型肝炎病毒完全清除,并且在抗病毒治疗终止后的几周至几个月内,所有肝细胞中的病毒复制均得以恢复。我们的结果表明,在缺乏能够清除至少一部分感染肝细胞并最终产生能够中和残留病毒的抗体的抗病毒免疫反应的宿主中,使用单一复制抑制剂消除慢性感染可能很困难。

相似文献

1
Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus.2'-碳脱氧鸟苷对慢性感染鸭乙型肝炎病毒的鸭子的抗病毒作用的表征
Hepatology. 1994 Feb;19(2):398-411.
2
Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.在慢性感染鸭的抗病毒治疗期间,肝细胞更新是鸭乙型肝炎病毒快速清除所必需的证据。
J Virol. 1994 Dec;68(12):8321-30. doi: 10.1128/JVI.68.12.8321-8330.1994.
3
Antiviral effects of PNA in duck hepatitis B virus infection model.肽核酸在鸭乙型肝炎病毒感染模型中的抗病毒作用。
Acta Pharmacol Sin. 2007 Oct;28(10):1652-8. doi: 10.1111/j.1745-7254.2007.00641.x.
4
Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.恩替卡韦抗病毒治疗联合暴露后“初免-加强”疫苗接种可清除鸭乙型肝炎病毒感染的肝细胞,并预防持续性感染的发生。
Virology. 2008 Apr 10;373(2):329-41. doi: 10.1016/j.virol.2007.11.032. Epub 2008 Jan 18.
5
[Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling].[利用湖北雏鸭建立鸭乙型肝炎病毒感染的体内模型]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008 Apr;22(2):113-5.
6
Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic-viral DNA, RNA, and protein expression.长期更昔洛韦化疗对先天性鸭乙型肝炎病毒体内感染的影响:对肝内病毒DNA、RNA及蛋白质表达的作用
Hepatology. 1996 Oct;24(4):766-73. doi: 10.1053/jhep.1996.v24.pm0008855174.
7
The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis.肝内残余的鸭乙型肝炎病毒共价闭合环状 DNA 的持续存在并不依赖于新的病毒 DNA 合成。
Virology. 2010 Oct 25;406(2):286-92. doi: 10.1016/j.virol.2010.07.013. Epub 2010 Aug 12.
8
In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L.卡罗来纳老鹳草植物提取物的体外和体内抗乙型肝炎病毒活性
Antiviral Res. 2008 Aug;79(2):114-20. doi: 10.1016/j.antiviral.2008.03.001. Epub 2008 Apr 7.
9
Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes.肝脏生长因子对慢性感染鸭肝细胞中嗜肝DNA病毒复制的影响。
J Hepatol. 2006 May;44(5):842-7. doi: 10.1016/j.jhep.2005.09.014. Epub 2005 Nov 2.
10
Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection.
Hepatology. 1998 Nov;28(5):1402-10. doi: 10.1002/hep.510280532.

引用本文的文献

1
Animal Models of Hepatitis B Virus Infection-Success, Challenges, and Future Directions.乙型肝炎病毒感染的动物模型——成功、挑战与未来方向。
Viruses. 2021 Apr 28;13(5):777. doi: 10.3390/v13050777.
2
Therapeutic strategies for a functional cure of chronic hepatitis B virus infection.慢性乙型肝炎病毒感染功能性治愈的治疗策略。
Acta Pharm Sin B. 2014 Aug;4(4):248-57. doi: 10.1016/j.apsb.2014.05.002. Epub 2014 Jun 18.
3
Dynamic changes of HBV DNA in serum and peripheral blood mononuclear cells of chronic hepatitis patients after lamivudine treatment.
拉米夫定治疗后慢性乙型肝炎患者血清及外周血单个核细胞中HBV DNA的动态变化
World J Gastroenterol. 2006 Jul 7;12(25):4061-3. doi: 10.3748/wjg.v12.i25.4061.
4
Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection.恩替卡韦治疗联合DNA疫苗接种用于持续性鸭乙型肝炎病毒感染
Antimicrob Agents Chemother. 2003 Aug;47(8):2624-35. doi: 10.1128/AAC.47.8.2624-2635.2003.
5
Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model.嘧啶和嘌呤类似物组合在鸭乙型肝炎病毒感染模型中的作用
Antimicrob Agents Chemother. 2003 Jun;47(6):1842-52. doi: 10.1128/AAC.47.6.1842-1852.2003.
6
Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro.阿德福韦对鸭乙型肝炎病毒感染的肝细胞在体内和体外的病毒DNA合成及共价闭合环状DNA形成的抑制作用。
Antimicrob Agents Chemother. 2002 Feb;46(2):425-33. doi: 10.1128/AAC.46.2.425-433.2002.
7
Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo.鸟嘌呤核苷类似物喷昔洛韦的长期治疗可在体内控制慢性鸭乙型肝炎病毒感染。
Antimicrob Agents Chemother. 1998 Aug;42(8):2132-7. doi: 10.1128/AAC.42.8.2132.
8
Inhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replication.2'-氟-5-甲基-β-L-阿拉伯呋喃糖基尿嘧啶对鸭乙型肝炎病毒复制的抑制作用
Antimicrob Agents Chemother. 1998 Feb;42(2):369-76. doi: 10.1128/AAC.42.2.369.
9
In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.(-)-顺式-5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊烷-5-基]胞嘧啶在土拨鼠肝炎病毒感染的土拨鼠体内的抗病毒活性及药代动力学
Antimicrob Agents Chemother. 1997 Oct;41(10):2076-82. doi: 10.1128/AAC.41.10.2076.
10
Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.将乙型肝炎治疗靶向肝脏。临床药代动力学考量
Clin Pharmacokinet. 1996 Aug;31(2):131-55. doi: 10.2165/00003088-199631020-00005.